Grufity logoGrufity logo

STERIS plc Stock Research

STE

191.28USD+2.48(+1.31%)Market Closed

Market Summary

USD191.28+2.48
Market Closed
1.31%

STE Alerts

STE Stock Price

STE RSI Chart

STE Valuation

Market Cap

19.0B

Price/Earnings (Trailing)

-680.66

Price/Sales (Trailing)

3.97

EV/EBITDA

24.13

Price/Free Cashflow

54.43

STE Price/Sales (Trailing)

STE Profitability

Operating Margin

43.03%

EBT Margin

0.70%

Return on Equity

-0.46%

Return on Assets

-0.26%

Free Cashflow Yield

1.84%

STE Fundamentals

STE Revenue

Revenue (TTM)

4.8B

Revenue Y/Y

0.58%

Revenue Q/Q

1.29%

STE Earnings

Earnings (TTM)

-27.9M

Earnings Y/Y

-13.78%

Earnings Q/Q

139.27%

Price Action

52 Week Range

158.76254.11
(Low)(High)

Last 7 days

3.3%

Last 30 days

1.5%

Last 90 days

3.6%

Trailing 12 Months

-20.3%

STE Financial Health

Current Ratio

2.48

Debt/Equity

0.46

Debt/Cashflow

0.28

STE Investor Care

Dividend Yield

0.94%

Dividend/Share (TTM)

1.8

Buy Backs (1Y)

0.71%

Diluted EPS (TTM)

-0.29

Peers (Alternatives to STERIS)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
108.0B
18.4B
9.81% 7.15%
45.81
5.86
7.84% 18.25%
107.3B
30.8B
-1.78% -26.78%
26.38
3.49
-3.19% -17.38%
89.4B
6.2B
12.38% -15.32%
67.62
14.37
8.97% -22.43%
70.1B
19.0B
7.04% -3.24%
43.54
3.69
-0.43% -8.78%
50.3B
5.4B
3.61% -29.72%
33.07
9.35
2.86% 1.25%
MID-CAP
7.2T
489.7M
14.55% 4.57%
82.2K
16.8K
106.51% 2464.23%
10.6B
847.1M
7.86% 25.46%
-5.3K
12.54
13.32% -137.89%
5.6B
1.0B
-2.14% -23.23%
32.76
5.52
6.76% 24.45%
3.7B
410.9M
4.99% -21.24%
-32.24
9.11
27.29% -14.60%
2.6B
801.2M
10.62% -65.08%
-27.7
3.27
14.00% -707.69%
SMALL-CAP
1.5B
138.6M
-18.17% -5.23%
-27.28
10.83
36.62% -10.44%
1.4B
820.0M
5.46% -11.22%
27.4
1.69
10.13% 701.59%
928.9M
154.8M
-4.61% -4.31%
-8.93
6
60.29% -2309.58%
833.4M
239.8M
0.46% -12.12%
-22.01
3.47
-4.74% -31.15%

Financials for STERIS

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue0.1%4,7844,7774,7734,5854,248
Gross Profit-0.8%2,1432,1602,1082,0161,825
Operating Expenses-0.2%2,0092,0131,5381,5911,347
  S&GA Expenses-0.4%1,4171,4221,4441,5031,270
  R&D Expenses0.7%10110195.0088.0079.00
EBITDA0.5%7777731,177957-
EBITDA Margin0.4%0.16*0.16*0.25*0.21*-
Earnings Before Taxes-39.6%34.0056.00478315379
EBT Margin-39.7%0.01*0.01*0.10*0.07*-
Interest Expenses6.0%99.0094.0090.0090.0078.00
Net Income-243.2%-27.93-8.14377244279
Net Income Margin-242.7%-0.01*0.00*0.08*0.05*-
Free Cahsflow-12.4%349399472397-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets3.0%10,80010,49011,18811,42411,690
  Current Assets4.7%1,9771,8881,8481,8791,927
    Cash Equivalents0.4%259258316348359
  Inventory7.7%694645620575595
  Net PPE6.3%1,6711,5721,5731,5531,522
  Goodwill4.0%3,8533,7054,3214,4045,115
Liabilities1.6%4,7514,6764,7694,8795,066
  Current Liabilities-8.7%796873908922904
.    Short Term Borrowings-60.3%60.00151151143128
  Long Term Debt-2,945----
    LT Debt, Non Current4.4%3,0022,8742,8462,9453,175
Shareholder's Equity3.9%6,0385,8136,4196,5326,624
  Retained Earnings4.5%1,7711,6952,0571,9991,990
Shares Outstanding-0.5%99.00100100100100
Minority Interest-10.4%10.0011.0012.0012.0012.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-5.2%713752819685701
  Share Based Compensation-1.6%40.0040.0040.0058.0054.00
Cashflow From Investing-9.6%-212-193-172-666-878
Cashflow From Financing10.6%-581-650-844116294
  Dividend Payments2.2%180176172163154
  Buy Backs80.4%18210170.0056.0028.00

Risks for STE

What is the probability of a big loss on STE?

35.4%


Probability that STERIS stock will be more than 20% underwater in next one year

29.2%


Probability that STERIS stock will be more than 30% underwater in next one year.

0%


Probability that STERIS stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does STE drawdown profile look like?

Y-axis is the maximum loss one would have experienced if STERIS was unfortunately bought at previous high price.

Drawdowns

Returns for STE

Cumulative Returns on STE

17.7%


10-Year Cumulative Returns

16.2%


7-Year Cumulative Returns

16.5%


5-Year Cumulative Returns

11.9%


3-Year Cumulative Returns

What are the long-term rolling returns for STE?

FIve years rolling returns for STERIS.

Annualized Returns

Which funds bought or sold STE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-27
Neo Ivy Capital Management
reduced
-66.05
-134,000
81,000
0.06%
2023-03-23
ETF MANAGERS GROUP, LLC
added
4.16
73,944
545,944
0.03%
2023-03-17
American Portfolios Advisors
added
12.41
-36,438
354,010
0.01%
2023-03-15
B. Riley Wealth Advisors, Inc.
added
16.34
63,025
284,025
0.01%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
30.38
2,549,500
8,238,500
0.01%
2023-03-06
Rockefeller Capital Management L.P.
added
20.95
5,346,000
20,917,000
0.10%
2023-03-03
TIAA, FSB
reduced
-14.87
-16,577
284,423
-%
2023-02-28
Voya Investment Management LLC
added
2.61
797,247
6,511,250
0.01%
2023-02-27
Gallagher Benefit Services, Inc.
new
-
216,446
216,446
0.04%
2023-02-24
SRS Capital Advisors, Inc.
reduced
-4.91
4,119
75,119
0.01%

1–10 of 47

Latest Funds Activity

Are funds buying STE calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own STE
No. of Funds

STERIS News

MarketWatch

Steris PLC stock rises Friday, still underperforms market.

MarketWatch,
9 hours ago

Stock Traders Daily

DirectorsTalk Interviews

Investors Chronicle

Top fund picks for a selection of goals.

Investors Chronicle,
9 days ago

MarketWatch

Nasdaq

Schedule 13G FIlings of STERIS

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 10, 2023
wcm investment management, llc
5.6%
5,563,771
SC 13G/A
Feb 09, 2023
vanguard group inc
11.99%
11,966,040
SC 13G/A
Feb 08, 2023
blackrock inc.
8.7%
8,710,879
SC 13G
Feb 08, 2023
massachusetts financial services co /ma/
5.0%
5,038,403
SC 13G
Feb 03, 2022
blackrock inc.
8.1%
8,128,575
SC 13G/A
Feb 11, 2021
janus henderson group plc
3.8%
3,253,302
SC 13G/A
Feb 10, 2021
vanguard group inc
10.58%
9,025,143
SC 13G/A
Feb 01, 2021
blackrock inc.
9.0%
7,688,347
SC 13G/A
Feb 13, 2020
janus henderson group plc
6.5%
5,482,611
SC 13G/A
Feb 06, 2020
blackrock inc.
8.7%
7,337,284
SC 13G

STE Fair Value

STERIS fair value in different scenarios

The table shows the Fair Value estimates for STERIS for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

93.54

-51.10%

124.94

-34.68%

221.37

15.73%

295.34

54.40%

363.68

90.13%
Current Inflation

86.36

-54.85%

113.22

-40.81%

195.01

1.95%

256.43

34.06%

313.07

63.67%
Very High Inflation

77.57

-59.45%

99.18

-48.15%

164.28

-14.12%

211.75

10.70%

255.45

33.55%

Historical STERIS Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of STERIS

View All Filings
Date Filed Form Type Document
Mar 07, 2023
4
Insider Trading
Feb 17, 2023
4
Insider Trading
Feb 10, 2023
SC 13G/A
Major Ownership Report
Feb 09, 2023
SC 13G/A
Major Ownership Report
Feb 08, 2023
SC 13G
Major Ownership Report
Feb 08, 2023
SC 13G
Major Ownership Report
Feb 08, 2023
8-K
Current Report
Feb 08, 2023
10-Q
Quarterly Report

Latest Insider Trading transactions for STE

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-03
Majors Cary L
sold
-218,742
190
-1,150
svp and president, healthcare
2023-02-15
Breeden Richard C
acquired
204,535
43.92
4,657
-
2022-12-02
Xilas Andrew
acquired
-
-
333
svp and gm, dental
2022-12-02
Xilas Andrew
sold (taxes)
-18,807
191
-98.00
svp and gm, dental
2022-12-01
Majors Cary L
sold
-308,016
192
-1,600
svp and president, healthcare
2022-10-10
Xilas Andrew
sold (taxes)
-25,115
168
-149
svp and gm, dental
2022-10-10
Xilas Andrew
acquired
-
-
503
svp and gm, dental
2022-10-07
Xilas Andrew
acquired
-
-
606
svp and gm, dental
2022-10-07
Xilas Andrew
sold (taxes)
-30,464
170
-179
svp and gm, dental
2022-10-03
Zangerle John Adam
sold (taxes)
-15,476
170
-91.00
sr. vp, gen counsel, and sec.

1–10 of 50

Daniel A. Carestio
13000
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company was founded in 1985 and is based in Dublin, Ireland.

STE Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:    
Revenues$ 1,200,517$ 1,196,985$ 2,357,008$ 2,165,407
Fair value adjustment related to convertible debt liability04,883027,806
Cost of revenues:    
Total cost of revenues668,182716,6411,306,8751,258,781
Gross Profit532,335480,3441,050,133906,626
Operating expenses:    
Selling, general, and administrative323,195344,799657,821738,551
2591744000490,5650490,5650
Research and development24,92818,83249,67937,024
Restructuring Costs6221088224
Total operating expenses838,750363,8411,198,153775,799
Income from operations(306,415)116,503(148,020)130,827
Non-operating expenses, net:    
Interest expense26,12323,03648,79744,848
Interest income and miscellaneous expense524(1,023)1,294(2,457)
Total non-operating expenses, net26,64726,89650,09170,197
Income before income tax expense(333,062)89,607(198,111)60,630
Income tax expense(17,831)19,9826,36512,907
Net Income(315,231)69,625(204,476)47,723
Less: Net Income Attributable to Noncontrolling Interest54(186)(453)(281)
Net income (loss) attributable to shareholders$ (315,285)$ 69,811$ (204,023)$ 48,004
Net income per common share [Abstract]    
Basic$ (3.15)$ 0.70$ (2.04)$ 0.51
Diluted(3.15)0.69(2.04)0.50
Cash dividends declared per common share outstanding$ 0.47$ 0.43$ 0.90$ 0.83
Product [Member]    
Revenues:    
Revenues$ 666,394$ 685,238$ 1,303,470$ 1,174,517
Cost of revenues:    
Cost of Goods and Services Sold351,079427,484683,934698,890
Service [Member]    
Revenues:    
Revenues534,123511,7471,053,538990,890
Cost of revenues:    
Cost of Goods and Services Sold$ 317,103$ 289,157$ 622,941$ 559,891

STE Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Current assets:  
Cash and cash equivalents$ 258,259$ 348,320
Accounts receivable (net of allowances of $22,196 and $24,371 respectively)780,113799,041
Inventories, net644,936574,999
Prepaid expenses and other current assets204,991156,637
Total current assets1,888,2991,878,997
Property, plant, and equipment, net1,572,3981,552,576
Operating Lease, Right-of-Use Asset174,073188,480
Goodwill3,705,1404,404,343
Intangible Assets, Net (Excluding Goodwill)3,077,4923,328,537
Other assets72,23470,661
Total assets10,489,63611,423,594
Current liabilities:  
Accounts payable233,308225,737
Accrued income taxes16,66126,873
Accrued payroll and other related liabilities133,839183,721
Capital Lease Obligations, Current33,96836,472
Short-term Debt151,000142,875
Accrued expenses and other304,039306,544
Total current liabilities872,815922,222
Long-term indebtedness2,873,9362,945,481
Deferred Income Taxes and Other Tax Liabilities, Noncurrent710,087780,619
Capital Lease Obligations, Noncurrent143,451155,056
Other Liabilities, Noncurrent75,90075,579
Total liabilities4,676,1894,878,957
Commitments and contingencies (see Note 8)
Common shares, with $0.001 par value; 500,000 authorized; 99,868 shares issued; and 100,067 shares outstanding4,705,1184,742,920
Retained earnings1,695,0871,999,244
Accumulated other comprehensive income(598,148)(209,808)
Total shareholders' equity5,802,0576,532,356
Noncontrolling interest11,39012,281
Total equity5,813,4476,544,637
Total liabilities and equity$ 10,489,636$ 11,423,594